Danai Ktena


Danai has more than 5 years’ pharma and consulting experience in local and regional roles on oncology, cardiovascular and orphan disease products. Her main area of focus across projects has been pricing and reimbursement, market access landscape assessments, gap analysis, HTA reviews, cost-effectiveness analyses, and other HEOR projects.

Danai holds a Master’s degree in Banking and International Finance and an MSc in Healthcare Management (major in Health Economics) from the National School of Public Health in Athens.

Outside of work Danai loves cooking, going out for walks with her dog, taking photos, watching movies, and meeting friends.